Eli Lilly and Company
Ralph Alvarez (Director) reports LLY insider transactions
AI-generated summary
Director Ralph Alvarez received 10.0107 shares as a grant valued at $12,416.67 on October 19, 2026. Following this transaction, the insider directly held 55,848.2299 shares of common stock.
Key facts
- Insider
- Ralph Alvarez · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | A · grantFootnotes F1 | +10.0107 | $1,240.34 | $12,416.67 | 55,848.2299 | Direct |
Footnotes
- F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
- F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
More LLY filings
- 4
Filed Nov 4, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.